EFFECTS OF NANDROLONE DECANOATE THERAPY ON BONE MASS AND CALCIUM-METABOLISM IN WOMEN WITH ESTABLISHED POST-MENOPAUSAL OSTEOPOROSIS - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY

被引：18

作者：

GENNARI, C

AGNUSDEI, D

GONNELLI, S

NARDI, P

机构：

来源：

MATURITAS | 1989年 / 11卷 / 03期

关键词：

D O I：

10.1016/0378-5122(89)90210-7

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：187 / 197

页数：11

共 24 条

[1]

Albright F., 1948, PARATHYROID GLANDS M

[2] EFFECT OF TESTOSTERONE THERAPY ON BONE-FORMATION IN AN OSTEOPOROTIC HYPOGONADAL MALE [J].

BARAN, DT ;

BERGFELD, MA ;

TEITELBAUM, SL ;

AVIOLI, LV .

CALCIFIED TISSUE RESEARCH, 1978, 26 (02) :103-106

[3] EFFECT OF METHANDROSTENOLONE ON POSTMENOPAUSAL BONE WASTING AS ASSESSED BY CHANGES IN TOTAL BONE-MINERAL MASS [J].

CHESNUT, CH ;

NELP, WB ;

BAYLINK, DJ ;

DENNEY, JD .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1977, 26 (03) :267-277

[4] STANOZOLOL IN POST-MENOPAUSAL OSTEOPOROSIS - THERAPEUTIC EFFICACY AND POSSIBLE MECHANISMS OF ACTION [J].

CHESNUT, CH ;

IVEY, JL ;

GRUBER, HE ;

MATTHEWS, M ;

NELP, WB ;

SISOM, K ;

BAYLINK, DJ .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1983, 32 (06) :571-580

[5]

DEQUEKER J, 1985, ACTA ENDOCRINOL-COP, V110, P45

[6]

DHEM A, 1980, CURR MED RES OPIN, V6, P606

[7]

FOGELMAN I, 1980, LANCET, V2, P667

[8] BONE-MINERAL CONTENT, CORTICAL THICKNESS AND FRACTURE RATE IN OSTEOPOROTIC WOMEN AFTER WITHDRAWAL OF TREATMENT WITH NANDROLONE DECANOATE, 1-ALPHA HYDROXYVITAMIN-D3, OR INTERMITTENT CALCIUM INFUSIONS [J].

GEUSENS, P ;

DEQUEKER, J ;

VERSTRAETEN, A ;

NIJS, J ;

VANHOLSBEECK, M .

MATURITAS, 1986, 8 (04) :281-289

[9]

GEUSENS P, 1986, BONE MINER, V1, P347

[10]

GORDAN GS, 1976, CLIN MANAGEMENT OSTE

← 1 2 3 →